Local Infiltration Analgesia for Hip Arthroscopy

Not Applicable

Completed

• Conditions: Pain
• Interventions: Procedure: Infiltration of local anesthetic; Procedure: Normal Saline Injection

• Registration Number: NCT01454518
• Lead Sponsor: Trinity Health Of New England

Brief Summary

The purpose of this study is to examine if ultrasound guided infiltration of local anesthetic solution around the hip joint will provide effective pain control after hip arthroscopy.

Detailed Description

Not available

Study Timeline

• Study Start: 2011-10
• Study First Submitted: 2011-10-06
• Study First Submitted QC: 2011-10-18
• Study First Posted: 2011-10-19
• Primary Completion: 2012-09
• Study Completion: 2013-02
• Status Verified: 2013-03
• Last Update Submitted: 2013-03-08
• Last Update Posted: 2013-03-11

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 36

Inclusion Criteria

• hip arthroscopy
• ages 18-80

Exclusion Criteria

• history of neurological disease
• diabetes
• pregnancy
• neuropathy
• chronic narcotic use
• allergy to local anesthetic solution
• inability to give consent or cooperate with the study protocol

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Infiltration of local anesthetic	Infiltration of local anesthetic	30 ml of ropivacaine 0.5% infiltrated around lateral anterior and medial aspect of hip joint with ultrasound guidance.
Normal Saline Injection	Normal Saline Injection	injection of 30ml normal saline infiltrated around lateral anterior and medial aspect of hip joint with ultrasound guidance.

Primary Outcome Measures

Name	Time	Method
Post operative opioid consumption.	Within 24 hours after surgery	Amount in milligrams of opioid consumption post surgery in the recovery room and for a 24 hour period.

Secondary Outcome Measures

Name	Time	Method
Pain scores in recovery room.	Within 24 hours of the surgery	Mesures of pain score using numeric pain rating scale (0=no pain, 10=worst pain) completed by patient in recovery room and every 6 hours for a 24 hour period after discharge from recovery room.

Trial Locations

Locations (1)

Saint Francis Hospital and Medical Center; 🇺🇸 Hartford, Connecticut, United States